Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Daiwa Capital Upgrades Pfizer to Outperform, Announces $51 Price Target

Daiwa Capital analyst Narumi Nakagiri upgrades Pfizer (NYSE:PFE) from Neutral to Outperform and announces $51 price target.
byBenzinga Newsdesk
February 7, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Daiwa Capital analyst Narumi Nakagiri upgrades Pfizer (NYSE:PFE) from Neutral to Outperform and announces $51 price target.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts